UnitedHealth rebuffs Cologuard

UnitedHealth Group Inc. (NYSE:UNH) on Monday instituted a medical policy that concludes the evidence is insufficient to support the diagnostic accuracy of fecal

Read the full 233 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE